Joseph Banno, MD
Cardiovascular Disease · Grand Rapids, MINPI 1306339064
Payments from drug & device makers
Across 130 payments — averaging $277.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$15K
- Medtronic$11K
- Boston Scientific$7K
- Philips North America LLC$525
- Biosense Webster, Inc.$440
- E.r. Squibb & Sons, L.L.C.$438
- plus $2K from 17 others
What the payments were for
- Grants$23,13664%
- Travel & lodging$6,28017%
- Food & beverage$6,10517%
- Education$5802%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 42 | $14,504 |
| Medtronic | 26 | $11,190 |
| Boston Scientific | 12 | $7,146 |
| Philips North America LLC | 3 | $525 |
| Biosense Webster, Inc. | 3 | $440 |
| E.r. Squibb & Sons, L.L.C. | 8 | $438 |
| Atricure, Inc. | 4 | $403 |
| Abiomed | 2 | $223 |
| Johnson & Johnson(2 entities) | 4 | $203 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $201 |
| Impulse Dynamics (USA) Inc. | 1 | $136 |
| Cardiovascular Systems Inc. | 2 | $120 |
| Bard Peripheral Vascular, Inc. | 1 | $114 |
| Novartis | 2 | $101 |
| Sumitomo Pharma America, Inc. | 3 | $78 |
| Amgen | 2 | $55 |
| AstraZeneca | 2 | $46 |
| Irhythm Technologies, Inc. | 2 | $40 |
| Heartflow, Inc. | 1 | $33 |
| Acist Medical Systems, Inc. | 1 | $32 |
| Boehringer Ingelheim | 2 | $28 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $28 |
| Cardiva Medical, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL BRADY$5,000
- ASSURITY$2,250
- TACTICATH$2,250
- GALLANT$1,504
- ENSITE PRECISION$1,083
- ENSITE$709
- (9124) LM Undivided$484
- Carto 3$440
- Micra$387
- SYNERGY ABLATION SYSTEM$275
- OPTIMIZER$272
- HeartMate 3 Left Ventricular Assist Device$200
- NA$188
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$167
- ONYX FRONTIER$163
- Impella$146
- CAMZYOS$128
- XARELTO$121
- WATCHMAN Access System$118
- RotarexS 6 F x 135 cm$114
How this compares
$36,101 in reported general payments places this provider in the 80th percentile of 760 cardiovascular disease providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 25 | $686 |
| Atorvastatin Calcium | 11 | $218 |
| Furosemide | 19 | $123 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Grand Rapids
- Jihad MustaphaGrand Rapids$1.9M
- Fadi SaabGrand Rapids$430K
- Stanley ChetcutiAnn Arbor$4.3M
- Sandeep KhuranaGrandville$2.3M
- Victor MolesAnn Arbor$2.1M
- Marschall RungeAnn Arbor$1.8M
- Sara SaberiAnn Arbor$1.6M
- Brian OneillDetroit$1.4M
- Vallerie McLaughlinAnn Arbor$1.4M
- Ahmad MizyedYpsilanti$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.